Loading
institutionsInstitution
TUM Klinikum rechts der Isar / CCC München
Munich's technical university hospital, one half of the Comprehensive Cancer Center Munich and a leader in PSMA imaging and radiopharmaceutical chemistry.
Also called: Klinikum rechts der IsarTechnical University of MunichComprehensive Cancer Center Munich (TUM)
Overview
The Klinikum rechts der Isar is the university hospital of the Technical University of Munich and, with the LMU, forms the CCC München, a German Cancer Aid Oncology Center of Excellence and DKTK partner site. Its nuclear medicine and radiopharmacy groups developed the radiohybrid PSMA ligands (rhPSMA) that became flotufolastat F-18, and run large theranostic programmes in prostate and neuroendocrine cancer. The TranslaTUM centre houses translational oncology, imaging and immunology, and the hospital has strong pancreatic surgery, haematology and gastrointestinal oncology programmes. Patients access molecular tumour boards and early-phase trials across both Munich university sites.
Location
Munich, DE
Type
university · Technische Universität München
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#145 · 34 points (0 Newsweek + 0 NCI + 34 from 17 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to TUM Klinikum, including child institutions. 438 works · 4,021 citations · 70% open access · 8% clinical trials · 2% reviews.
Oncology works per year
1012022
1012023
852024
792025
722026
Most works
- İhsan Ekin Demir47 works
- Katja Steiger29 works
- Helmut Frieß29 works
- Hana Algül27 works
- Maximilian Reichert26 works
- Güralp O. Ceyhan24 works
- Helmut Friess21 works
- Carsten Jäger20 works
- Roland Rad20 works
- Volker Heinemann17 works
Most cited
- Radiopharmaceutical chemistry and PSMA theranostics
- TranslaTUM
- Pancreatic surgery
- Haematology
- CCC München (with LMU)
Martin Siess
Chairman of the Board and Medical Director
Hospital managementAcademic medicine
Medical Director and board chair of TUM Klinikum rechts der Isar, the university hospital of the Technical University of Munich.
Wolfgang A. Weber
Chair of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich
Molecular imagingPET response assessmentTheranostics
Nuclear medicine physician who established PET response criteria and leads Munich's radiopharmaceutical development pipeline.
Similar pages
- InstitutionChulabhorn Hospital / Chulabhorn Royal Academy
Shares Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- InstitutionPostgraduate Institute of Medical Education and Research, Chandigarh
Shares FAPI PET, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- PersonKen Herrmann
Shares FAPI PET, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- InstitutionEuropean Association of Nuclear Medicine
Shares LMU Klinikum München, Theranostics, FAPI PET, Lutetium-177 dotatate.
- InstitutionInselspital, Bern University Hospital / University Cancer Center Inselspital
Shares Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- InstitutionWest German Cancer Center (WTZ), University Hospital Essen
Shares German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan.
- InstitutionIRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)
Shares Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- InstitutionSociety of Nuclear Medicine and Molecular Imaging
Shares Wolfgang A. Weber, Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan.
cancers
fronts
technologies
drugs
ApprovedRadioligand therapy (beta)
Lutetium-177 dotatate · Lutathera
ApprovedRadioligand therapy (beta)
Lutetium-177 vipivotide tetraxetan · Pluvicto